Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Trickey

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|May 18, 2023
Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiationMathieu Chalouni, Adam Trickey, Suzanne M Ingle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2017
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)Adam Trickey, Margaret T May, Philipp Schommers, et al.
BMC Infectious Diseases|December 20, 2023
Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studiesAdam Trickey, Leigh F Johnson, Fai Fung, et al.
The Lancet. Public Health|September 30, 2023
All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaborationSophia M Rein, Fiona C Lampe, Suzanne M Ingle, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The International Journal on Drug Policy|June 22, 2025
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, VietnamAdam Trickey, Josephine G Walker, Pham Minh Khue, et al.
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
The Lancet. HIV|January 27, 2024
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studiesAdam Trickey, Kathleen McGinnis, M John Gill, et al.
International Journal of Cancer|February 1, 2020
Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studiesAdam Trickey, Margaret T May, M John Gill, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|May 18, 2023
Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiationMathieu Chalouni, Adam Trickey, Suzanne M Ingle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2017
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)Adam Trickey, Margaret T May, Philipp Schommers, et al.
BMC Infectious Diseases|December 20, 2023
Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studiesAdam Trickey, Leigh F Johnson, Fai Fung, et al.
The Lancet. Public Health|September 30, 2023
All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaborationSophia M Rein, Fiona C Lampe, Suzanne M Ingle, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The International Journal on Drug Policy|June 22, 2025
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, VietnamAdam Trickey, Josephine G Walker, Pham Minh Khue, et al.
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
The Lancet. HIV|January 27, 2024
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studiesAdam Trickey, Kathleen McGinnis, M John Gill, et al.
International Journal of Cancer|February 1, 2020
Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studiesAdam Trickey, Margaret T May, M John Gill, et al.
Pageof 9